Schonfeld Strategic Advisors LLC Alector, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$5.2 - $8.77 $91,291 - $153,966
17,556 New
17,556 $113,000
Q3 2022

Nov 14, 2022
BUY
$8.19 - $13.2 $117,534 - $189,433
14,351 New
14,351 $136,000
Q4 2021

Feb 14, 2022
SELL
$19.35 - $25.54 $363,780 - $480,152
-18,800 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$21.65 - $39.49 $110,415 - $201,399
-5,100 Reduced 21.34%
18,800 $429,000
Q2 2021

Aug 16, 2021
BUY
$15.5 - $22.48 $370,450 - $537,272
23,900 New
23,900 $499,000

Others Institutions Holding ALEC

# of Institutions
168
Shares Held
57.8M
Call Options Held
146K
Put Options Held
90.8K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email